PREvention of Cardiovascular and DiabEtic kidNey disease in Type 2 Diabetes (PRECIDENTD)

PI(s): Brendan Everett and Robert J. Glynn

Project Summary: This 7-year randomized controlled trial seeks to measure the comparative effectiveness of newer diabetes medications in preventing cardiovascular and kidney disease among patients with type 2 diabetes. Additionally, researchers want to learn about serious side effects in the treatment groups and their effect on patients’ quality of life. Patient outcomes, tracked through electronic health records and patient reports, will contribute to new understandings to guide patients and providers as they decide which diabetes medications are best for patients.

Study Design: Multi-CRN Data only Observational

Sponsor: PCORI®

Coordinating Center: Brigham and Women’s Hospital

PaTH Network Logo
Twitter Logo Facebook Logo LinkedIn Logo YouTube Logo

Copyright 2016 | PaTH Network